T1	GGPs 1009 1019	complement
T3	Subject 2033 2041	patients
T5	Cell 118 125	B cells
T6	Anatomical_entity 583 589	Plasma
T12	Disorder 1834 1841	disease
T14	Cell 729 740	plasmablast
T16	Disorder 162 192	idiopathic pulmonary  fibrosis
T17	Disorder 194 197	IPF
T20	Anatomical_entity 1110 1115	lungs
T22	Cell 398 404	B cell
T23	Cell 472 479	B cells
T26	Method_cue 561 581	immunohistochemistry
T27	Cell 1171 1177	B cell
T30	Subject 91 99	patients
T31	Cellular_process 1191 1206	differentiation
T35	Disorder 1055 1058	IPF
T38	Cell 2022 2029	B cells
T43	Cell 1762 1769	B cells
T44	Disorder 674 677	IPF
T45	Disorder 1442 1445	IPF
T46	Disorder 215 239	restrictive lung disease
T47	GGPs 7 30	B lymphocyte stimulator
T49	Method_cue 644 649	ELISA
T51	Subject 436 444	patients
T52	Disorder 1258 1261	IPF
T53	Disorder 873 876	IPF
T54	Anatomical_entity 1059 1064	lungs
T56	Method_cue 502 516	flow cytometry
T59	Organic_compound_other 262 277	glucocorticoids
T62	Cellular_process 841 856	differentiation
T63	Disorder 1525 1528	IPF
T64	Subject 1861 1868	patient
T65	Entity_Property 202 213	progressive
T67	Anatomical_entity 974 986	perivascular
T74	Disorder 1922 1925	IPF
T75	Disorder 1793 1796	IPF
T76	Artificial_process 300 309	therapies
T77	GGPs 1556 1560	BLyS
T79	Disorder 1331 1368	chronic obstructive pulmonary disease
T80	Subject 1446 1454	patients
T81	Anatomical_entity 0 6	Plasma
T83	GGPs 1399 1403	BLyS
T86	Cellular_process 1178 1186	survival
T87	GGPs 1142 1146	BLyS
T88	Cell 663 670	B cells
T91	Subject 877 884	patient
T93	Disorder 61 90	idiopathic pulmonary fibrosis
T95	Subject 1797 1805	patients
T99	GGPs 623 627	BLyS
T101	GGPs 1645 1649	BLyS
T102	GGPs 1774 1778	BLyS
T103	Anatomical_entity 1117 1123	Plasma
T104	Disorder 2052 2064	lung disease
E1	Cellular_process:T31 Theme:T27
E3	Cellular_process:T62 
E4	Artificial_process:T76 Instrument:T59
E5	Cellular_process:T86 Theme:T27
N3	Reference T1 UMLS:C0009498	Complement System Proteins
N6	Reference T3 UMLS:C0030705	Patients
N13	Reference T5 UMLS:C0004561	B-Lymphocytes
N14	Reference T6 UMLS:C0032105	Plasma
N30	Reference T12 UMLS:C0012634	Disease
N37	Reference T14 UMLS:C0229657	Plasmablast (cell)
N40	Reference T16 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N43	Reference T17 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N55	Reference T20 UMLS:C0024109	Lung
N60	Reference T22 UMLS:C0004561	B-Lymphocytes
N62	Reference T23 UMLS:C0004561	B-Lymphocytes
N71	Reference T26 UMLS:C0021044	Immunohistochemistry
N74	Reference T27 UMLS:C0004561	B-Lymphocytes
N83	Reference T30 UMLS:C0030705	Patients
N89	Reference E1 UMLS:C0007589	Cell Differentiation process
N98	Reference T35 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N105	Reference T38 UMLS:C0004561	B-Lymphocytes
N119	Reference T43 UMLS:C0004561	B-Lymphocytes
N120	Reference T44 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N123	Reference T45 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N127	Reference T46 UMLS:C0085581	Restrictive lung disease
N131	Reference T47 UMLS:C0767393	TALL-1 protein
N138	Reference T49 UMLS:C0014441	Enzyme-Linked Immunosorbent Assay
N141	Reference T51 UMLS:C0030705	Patients
N144	Reference T52 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N147	Reference T53 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N150	Reference T54 UMLS:C0024109	Lung
N156	Reference T56 UMLS:C0016263	Flow Cytometry
N179	Reference E3 UMLS:C0007589	Cell Differentiation process
N181	Reference T63 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N184	Reference T64 UMLS:C0030705	Patients
N187	Reference T65 UMLS:C0205329	Progressive
N190	Reference T67 UMLS:C0442165	Perivascular
N208	Reference T74 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N212	Reference T75 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N215	Reference E4 UMLS:C0087111	Therapeutic procedure
N226	Reference T80 UMLS:C0030705	Patients
N228	Reference T81 UMLS:C0032105	Plasma
N243	Reference E5 UMLS:C0007620	Cell Survival
N251	Reference T88 UMLS:C0004561	B-Lymphocytes
N258	Reference T91 UMLS:C0030705	Patients
N264	Reference T93 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N269	Reference T95 UMLS:C0030705	Patients
N297	Reference T103 UMLS:C0032105	Plasma
N299	Reference T104 UMLS:C0024115	Lung diseases
N1	Reference T79 UMLS:C0024117	Chronic Obstructive Airway Disease
T24	GGPs 590 621	B lymphocyte stimulating factor
N2	Reference T24 UMLS:C0767393	TALL-1 protein
T90	Cell 923 937	CD20(+) B cell
N7	Reference T59 UMLS:C0017710	Glucocorticoids
N8	Reference T99 UMLS:C0767393	TALL-1 protein
N9	Reference T87 UMLS:C0767393	TALL-1 protein
N10	Reference T83 UMLS:C0767393	TALL-1 protein
N12	Reference T77 UMLS:C0767393	TALL-1 protein
N15	Reference T101 UMLS:C0767393	TALL-1 protein
N17	Reference T102 UMLS:C0767393	TALL-1 protein
T39	GGPs 697 699	Ag
N19	Reference T39 UMLS:C0003320	Antigens
T105	Measurement 1460 1486	pulmonary artery pressures
N20	Reference T105 UMLS:C0428642	Pulmonary artery pressure
N5	Reference T90 UMLS:C1267890	Lymphocyte positive for CD20 antigen
T106	Subject 1254 1257	110
T107	Subject 1369 1377	subjects
N22	Reference T107 UMLS:C0681850	Study Subject
N21	Reference T106 UMLS:C0681850	Study Subject
T108	Subject 1328 1330	90
N25	Reference T108 UMLS:C0681850	Study Subject
T109	Subject 1294 1296	53
N27	Reference T109 UMLS:C0681850	Study Subject
T110	Subject 678 686	subjects
N28	Reference T110 UMLS:C0681850	Study Subject
T111	Subject 1529 1537	subjects
N31	Reference T111 UMLS:C0681850	Study Subject
T112	Subject 781 789	controls
N32	Reference T112 UMLS:C0009932	Control Groups
R1	Subject_Disorder Arg1:T30 Arg2:T93	
R2	Subject_Disorder Arg1:T110 Arg2:T44	
R3	Subject_Disorder Arg1:T91 Arg2:T53	
R4	Subject_Disorder Arg1:T106 Arg2:T52	
R5	Subject_Disorder Arg1:T108 Arg2:T79	
R6	member_of Arg1:T106 Arg2:T107	
R7	member_of Arg1:T109 Arg2:T107	
R8	member_of Arg1:T108 Arg2:T107	
R9	Subject_Disorder Arg1:T80 Arg2:T45	
R10	Subject_Disorder Arg1:T111 Arg2:T63	
R11	Subject_Disorder Arg1:T95 Arg2:T75	
T114	Biological_process 146 158	pathogenesis
E9	Biological_process:T114 Theme:T16
N34	Reference E9 UMLS:C0699748	Pathogenesis
T33	Anatomical_entity 958 969	parenchymal
N36	Reference T33 UMLS:C4277702	Parenchymal Tissue
T29	Negative_regulation 1577 1587	diminished
E11	Negative_regulation:T29 
T115	Biological_process 1926 1938	pathogenesis
E12	Biological_process:T115 Theme:T74
N39	Reference E12 UMLS:C0699748	Pathogenesis
T116	Correlation 130 138	involved
E13	Correlation:T116 Theme:T5 Theme2:E9 Cue:T66
N23	Reference E11 UMLS:C3463820	Inhibition
T13	Positive_regulation 1151 1159	obligate
E15	Positive_regulation:T13 Cause:T87 Theme:E1
N33	Reference E15 UMLS:C1879547	Activation action
E16	Positive_regulation:T13 Cause:T87 Theme:E5
N44	Reference E16 UMLS:C1879547	Activation action
T36	Cellular_process 938 948	aggregates
E2	Cellular_process:T36 Theme:T90
N45	Reference E2 UMLS:C0007580	Cell Aggregation
T10	Localization 1020 1031	depositions
E17	Localization:T10 Theme:T1
N24	Reference E17 UMLS:C4055506	Accumulation
N41	Reference E13 UMLS:C0332281	Associated with
T4	Correlation 1425 1435	correlated
E14	Correlation:T4 Theme:T83 Theme2:T105 disorder:T45
N48	Reference E14 UMLS:C0332281	Associated with
T21	Correlation 857 867	correlated
E18	Correlation:T21 Theme:E3 Theme2:T28
N49	Reference E18 UMLS:C0332281	Associated with
T28	Measurement 885 897	lung volumes
N53	Reference T28 UMLS:C0024129	Lung Volume Measurements
T8	GGPs 987 1003	immune complexes
N11	Reference T8 UMLS:C0003313	Immune complex
T40	Cellular_process 700 714	differentiated
E7	Cellular_process:T40 Theme:T88
N52	Reference E7 UMLS:C0007589	Cell Differentiation process
T55	Disorder 202 239	progressive, restrictive lung disease
N35	Reference T55 UMLS:C0085581	Restrictive lung disease
R16	member_of Arg1:T55 Arg2:T46	
T57	Cellular_process 42 57	differentiation
E8	Cellular_process:T57 Theme:T61 disorder:T93
N57	Reference E8 UMLS:C0007589	Cell Differentiation process
T61	Cell 35 41	B cell
N58	Reference T61 UMLS:C0004561	B-Lymphocytes
T66	Speculation_cue 105 117	hypothesized
A1	Speculated E13
R15	member_of Arg1:T16 Arg2:T46	
R18	Subject_Disorder Arg1:T3 Arg2:T104	
T25	Negation_cue 248 261	refractory to
